Clinical Trials at OhioHealth O'Bleness Hospital
As of July 2026, 13 paid clinical trials are recruiting at OhioHealth O'Bleness Hospital, located at 65 HOSPITAL DR, ATHENS, OH 45701-2302, phone (318) 267-8026 in Athens, Ohio. Active studies at this site cover conditions such as Developmental Language Disorders, Malignant Female Reproductive System Neoplasm and Ovarian Carcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
13 clinical trials at OhioHealth O'Bleness Hospital
·Clear filters·Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Common conditions studied in Athens
- Developmental Language Disorders (2 active studies)
- Malignant Female Reproductive System Neoplasm (2 active studies)
- Ovarian Carcinoma (2 active studies)
- Recurrent Endometrial Carcinoma (2 active studies)
- Recurrent Malignant Female Reproductive System Neoplasm (2 active studies)
- Recurrent Malignant Solid Neoplasm (2 active studies)
Leading research sponsors in Athens
- Ohio University
- NRG Oncology
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Athens?
There are approximately 23 recruiting clinical trials in Athens, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Athens pay participants?
Most recruiting trials in Athens compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Athens?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Athens?
The most common conditions under active study in Athens include Developmental Language Disorders (2), Malignant Female Reproductive System Neoplasm (2), Ovarian Carcinoma (2), Recurrent Endometrial Carcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Athens?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Athens on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Athens?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Athens?
Recruiting research sites in Athens include OhioHealth O'Bleness Hospital, Ohio University, Athens Eye Care, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Athens right now?
The largest active categories in Athens are Cancer & tumors (12), Mental health & behavior (1), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of OhioHealth O'Bleness Hospital?
OhioHealth O'Bleness Hospital is located at 65 HOSPITAL DR, ATHENS, OH 45701-2302. Use the Google Maps link in the intro above to get directions.
How do I contact OhioHealth O'Bleness Hospital?
You can reach OhioHealth O'Bleness Hospital by phone at (318) 267-8026. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.